Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psoriatic Disease and Related Manifestations; Real World Evidence in Brazilian Secukinumab Environment

NCT06666114 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT06666114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06666114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psoriatic Disease and Related Manifestations; Real World Evidence in Brazilian Secukinumab Environment
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
August 3, 2021
Completion date
October 10, 2023
Enrollment
232 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis (pso), psoriatic arthritis (psa)